MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.

Clinical Ink

23andMe

Repare Therapeutics

Acceleron Pharma

Athersys

Humanigen

Nevro

Rhythm Pharmaceuticals

Syndax Pharmaceuticals

TCR2

TriNetX

Verastem Oncology

Harpoon Therapeutics

Semma Therapeutics

ITeos Therapeutics

Cullinan Oncology

Dyne Therapeutics

Entrada Therapeutics

Epizyme

MPM BioImpact

MPM Capital

GoDaddy SSL

WP Engine

MailChimp SPF

Comcast

Mimecast

DNS Made Easy DNS

Founder, President and Chief Executive Officer - Sieben Therapeutics

Detlev Biniszkiewicz

Partner, Chief Financial Officer and Chief Operating Officer

Kristen Laguerre

Owner

Rocky Moore

Chairman & CEO

Tom Ma

Managing Director

Bard Geesaman

Sales and Support

Christian Desmarteaux

Director of Information Technology

David Thompson

Ed Hurwitz

Kazumi Shiosaki

Director of Investor Relations

Kellie Neville

Robert Horvitz

Jon Wigginton

David P. Ryan

Thomas Ebeling

VAS Narasimhan

Anthony Rosenberg

Briggs Morrison

Elizabeth Stoner

Executive Partner

Dan Hicklin

Ansbert Gadicke

Managing Director and Co-Founder

Matthew Roden

Shinichiro Fuse

Brian Goodman

Partner

23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Boston Venture Capital Investors

Early Stage Venture Investors with Investments in Silicon Valley

Early Stage Venture Investors with Investments in La Jolla, California

Northeastern US Late Stage Venture Investors

MPM Capital is a healthcare investment firm that invests in companies developing therapeutic technologies in oncology. The company invests in life sciences companies that seek to cure diseases by translating science into clinical outcomes. The company prefers to invest in the biotechnology, healthcare, and life sciences sectors.

MPM Capital second Oncology Impact Fund

MPM Oncology Innovations Fund

MPM Bioventures 2018

MPM UBS Oncology Impact Fund

MPM BioVentures 2014 LP

MPM Bio 2014 NVS Strategic Fund

MPM SunStates Fund

MPM Bio V NVS Strategic Fund

MPM BioVentures V

Advertising, Business and Retail Services

Boston

Massachusetts

United States

North America

M3M Capital Flats In Sector 113 - Your Urban Adventure Starts Here

What VCs really think of the market right now with MPM Capital, Endeavor and Two Bear Capital

HTML5

DigiCert

Modernizr

Wordpress

Vimeo

jQuery

Google Compute Engine

F5 NGINX

Google Maps API

Google Analytics

RA Capital is a healthcare venture capital firm that focuses on early-stage ventures in the biotechnology, pharmaceuticals, and medical technology sectors.

RA Capital

OrbiMed is a venture capital firm specializing in the healthcare industry, particularly in biotechnology, pharmaceuticals, and medical technology.

OrbiMed

Rock Health is a venture capital firm that invests in startups at the intersection of healthcare and technology.

Rock Health

BoxGroup is a venture capital firm that invests in early-stage companies across various industries, including healthcare.

BoxGroup

HealthTech Capital is a venture capital firm focused on investing in early-stage healthcare and life sciences companies.

HealthTech Capital

Karista VC is a venture capital firm that invests in healthcare and technology companies at various stages of development.

Karista VC

Foresite Capital is a venture capital firm that focuses on investing in transformative healthcare companies, particularly in biotechnology.

Foresite Capital

Kamylon Capital is a competitor of MPM Capital in the healthcare sector, with a focus on seed, early, and later stage venture, and private equity investments.

Kamylon Capital

Elaia is a biotech venture capital company shaping the biotech industry's future with breakthrough innovations.

Elaia

MPM Capital is a healthcare investment firm that focuses on early-stage ventures in the biotechnology, pharmaceuticals, and medical technology sectors. The company leverages its deep experience and network in the healthcare industry to identify and invest in promising life sciences companies, providing them with strategic guidance and capital to develop innovative therapies and technologies.

news impact assignment basic	general	Nov 20, 2024 11:45 AM	250c5bef
public peers	general	May 15, 2024 10:38 AM	477b4394
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	64da1dcc
crunchbase profile	general	Oct 29, 2024 7:59 AM	65c79f59
li profile	general	May 15, 2024 10:38 AM	6ea93267
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	4cdaaeb6
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MPMCAPITAL

MPM Capital